Minimally Invasive Glaucoma Surgery Devices Market: By Surgery, By Target, By Product, By End-user and Geography

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Minimally Invasive Glaucoma Surgery Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Surgery (Glaucoma in Conjunction with Cataract and Stand Alone Glaucoma), By Target (Trabecular Meshwork, Suprachoroidal Space and Other), By Product (MIGS Stents, MIGS Shunts and others), By End-user (Eye Hospitals, Ophthalmology Clinics and Outpatient Surgical Centres) and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market size was valued at US$ 635.4 million in 2023 and is poised to grow at 5.9% CAGR during 2024-2030. Minimally Invasive Glaucoma Surgery (MIGS) devices are advanced medical devices designed to treat glaucoma with less tissue trauma compared to traditional glaucoma surgeries. These devices aim to lower intraocular pressure (IOP) in the eye by improving the outflow of aqueous humor, thereby preventing further optic nerve damage and vision loss. The increasing prevalence of glaucoma in the elderly population drives demand for MIGS devices. Moreover, patients and surgeons prefer minimally invasive options due to quicker recovery times and fewer complications which enhances the market growth.

However, MIGS devices and procedures can be expensive, limiting their accessibility in some regions. Also, the need for specialized training to perform MIGS limits its widespread adoption. Ongoing research and development can lead to the introduction of more effective and affordable MIGS devices which is an opportunity for the market growth.

Market Key Developments

  • In 2022: Glaukos received FDA clearance for the iStent Infinite Trabecular Micro-Bypass System.
  • In 2020: The FDA approved the iStent inject® W, an advanced trabecular micro-bypass stent designed for primary open-angle glaucoma. This approval marked a significant milestone in providing patients with a safer, minimally invasive treatment option.

summary download arrow Download Free Sample

Minimally Invasive Glaucoma Surgery Devices Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.9%

Largest Market

North-America

Fastest Growing Market

North-America

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Dynamics

The global glaucoma market is growing because to factors like the ageing population, rising rates of glaucoma, increased demand for operations combining glaucoma and cataracts, and heightened attention from major manufacturers in the MIGS stent development. Additionally, AbbVie bought Allergan plc in 2019 acquired eye care products such as Xen, Durysta, Ozurdex, and Refresh/Optive. With these remarkable improvements, regional firms are vying for market share in minimally invasive glaucoma surgery devices. As a result, the market is growing faster as MIGS devices are adopted more widely. The lack of qualified specialists and reimbursement constraints for MIGS devices, however, are impeding market expansion.

Furthermore, the quick switch from glaucoma drugs to minimally invasive glaucoma operations present an opportunity for the growth of the MIGS device industry. Moreover, advancements in technology have brought about a revolutionary shift in the management of glaucoma through minimally invasive glaucoma surgery (MIGS). The development of novel stent technologies, such as the iStent inject® W by Glaukos Corporation, has significantly enhanced the safety and efficacy of MIGS procedures. These stents are designed to be implanted with minimal tissue disruption, facilitating better aqueous humor outflow and lowering intraocular pressure effectively.

Minimally Invasive Glaucoma Surgery Devices Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 635.4 million

Market CAGR

5.9%

By Surgery

  • Glaucoma in Conjunction with Cataract
  • Stand Alone Glaucoma

By Target

  • Trabecular Meshwork
  • Suprachoroidal Space
  • Others

By Product

  • MIGS Stents
  • MIGS Shunts
  • Others

By End User

  • Eye Hospitals
  • Ophthalmology Clinics
  • Outpatient Surgical Centres

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Key Features of the Report

  • The minimally invasive glaucoma surgery devices market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

MIGS devices are used to lower intraocular pressure in patients with glaucoma by improving the outflow of aqueous humor in a minimally invasive manner.

MIGS procedures are preferred because they involve less tissue trauma, quicker recovery times, and fewer complications compared to traditional surgeries.

Glaukos Corporation received FDA approval in 2020 for the iStent inject® W, a trabecular micro-bypass stent.

North America is leading the market due to its advanced healthcare infrastructure, high prevalence of glaucoma, and supportive government policies.

The main challenges include high costs, lack of skilled professionals, and stringent regulatory requirements.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Minimally Invasive Glaucoma Surgery Devices Market Introduction 
2.1.Global Minimally Invasive Glaucoma Surgery Devices Market  - Taxonomy
2.2.Global Minimally Invasive Glaucoma Surgery Devices Market  - Definitions
2.2.1.Surgery
2.2.2.Target
2.2.3.Product
2.2.4.End-user
2.2.5.Region
3.Global Minimally Invasive Glaucoma Surgery Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Minimally Invasive Glaucoma Surgery Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Minimally Invasive Glaucoma Surgery Devices Market  By Surgery, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Glaucoma in Conjunction with Cataract
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Stand Alone Glaucoma
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Minimally Invasive Glaucoma Surgery Devices Market  By Target, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Trabecular Meshwork
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Suprachoroidal Space
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Minimally Invasive Glaucoma Surgery Devices Market  By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. MIGS Stents
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. MIGS Shunts
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Minimally Invasive Glaucoma Surgery Devices Market  By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Eye Hospitals
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Ophthalmology Clinics
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Outpatient Surgical Centres
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Minimally Invasive Glaucoma Surgery Devices Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Minimally Invasive Glaucoma Surgery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Surgery Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Glaucoma in Conjunction with Cataract
10.1.2.Stand Alone Glaucoma
10.2.  Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Trabecular Meshwork
10.2.2.Suprachoroidal Space
10.2.3.Others
10.3.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.MIGS Stents
10.3.2.MIGS Shunts
10.3.3.Others
10.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Eye Hospitals
10.4.2.Ophthalmology Clinics
10.4.3.Outpatient Surgical Centres
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Minimally Invasive Glaucoma Surgery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Surgery Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Glaucoma in Conjunction with Cataract
11.1.2.Stand Alone Glaucoma
11.2.  Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Trabecular Meshwork
11.2.2.Suprachoroidal Space
11.2.3.Others
11.3.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.MIGS Stents
11.3.2.MIGS Shunts
11.3.3.Others
11.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Eye Hospitals
11.4.2.Ophthalmology Clinics
11.4.3.Outpatient Surgical Centres
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Minimally Invasive Glaucoma Surgery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Surgery Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Glaucoma in Conjunction with Cataract
12.1.2.Stand Alone Glaucoma
12.2.  Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Trabecular Meshwork
12.2.2.Suprachoroidal Space
12.2.3.Others
12.3.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.MIGS Stents
12.3.2.MIGS Shunts
12.3.3.Others
12.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Eye Hospitals
12.4.2.Ophthalmology Clinics
12.4.3.Outpatient Surgical Centres
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Minimally Invasive Glaucoma Surgery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Surgery Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Glaucoma in Conjunction with Cataract
13.1.2.Stand Alone Glaucoma
13.2.  Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Trabecular Meshwork
13.2.2.Suprachoroidal Space
13.2.3.Others
13.3.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.MIGS Stents
13.3.2.MIGS Shunts
13.3.3.Others
13.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Eye Hospitals
13.4.2.Ophthalmology Clinics
13.4.3.Outpatient Surgical Centres
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Minimally Invasive Glaucoma Surgery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Surgery Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Glaucoma in Conjunction with Cataract
14.1.2.Stand Alone Glaucoma
14.2.  Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Trabecular Meshwork
14.2.2.Suprachoroidal Space
14.2.3.Others
14.3.  Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.MIGS Stents
14.3.2.MIGS Shunts
14.3.3.Others
14.4.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Eye Hospitals
14.4.2.Ophthalmology Clinics
14.4.3.Outpatient Surgical Centres
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Alcon Inc.
15.2.2.ALLERGAN PLC.
15.2.3.Corza Ophthalmology
15.2.4.ELLEX MEDICAL LASERS LTD.
15.2.5.Glaukos Corporation.
15.2.6.IRIDEX Corporation
15.2.7.ISTAR MEDICAL SA
15.2.8.IVANTIS INC.
15.2.9.Lumenis Be Ltd.
15.2.10.NOVARTIS INTERNATIONAL AG
15.2.11.Ziemer Ophthalmic Systems AG
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Alcon Inc.
  • ALLERGAN PLC.
  • Corza Ophthalmology
  • ELLEX MEDICAL LASERS LTD.
  • Glaukos Corporation.
  • IRIDEX Corporation
  • ISTAR MEDICAL SA
  • IVANTIS INC.
  • Lumenis Be Ltd.
  • NOVARTIS INTERNATIONAL AG
  • Ziemer Ophthalmic Systems AG

Related Industry Reports

Minimally Invasive Orthopedic Imaging Devices Market

Switzerland Minimally Invasive Surgical Instruments Market

Minimally Invasive Surgical Instruments Market

Minimally Invasive Surgery Devices Market